Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences
ACCESSWIRE
21 May 2021, 21:43 GMT+10
SAN DIEGO, CA / ACCESSWIRE / May 21, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled intragastric balloon system for the treatment of obesity, is taking this opportunity to remind its stockholders to vote on all the proposals related to the proposed merger with ReShape Lifesciences Inc. in advance of the upcoming reconvened special meeting of Obalon stockholders (the Special Meeting )
on May 25, 2021, at 8:30 a.m. PT.
All stockholders are highly encouraged to vote by phone or email on this critical transaction. Without the required stockholder approval, the merger will not be able to be completed. The failure to complete the merger may result in, among other things, a material adverse effect on Obalon and its sto
Obalon Therapeutics Stockholders Special Meeting Adjourned to May 25, 2021
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.
Obalon Therapeutics Stockholders Special Meeting Adjourned to May 25, 2021
londonmercury.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from londonmercury.com Daily Mail and Mail on Sunday newspapers.
ReShape Lifesciences Inc.: Obalon Therapeutics, Inc. Urges Stockholders to IMMEDIATELY Vote FOR All Proposals Related to the Merger with ReShape Lifesciences Inc
IMMEDIATELY vote
FOR the proposals put forth in its proxy statement to be voted on at the May 13, 2021 special meeting of stockholders, all of which relate to the proposed merger with ReShape Lifesciences Inc., a global weight-loss solutions company offering an integrated portfolio of proven products and services that manage and treat obesity and associated metabolic disease. We are urging all of our stockholders to take a few minutes to vote by phone or email on this important transaction, said Obalon CEO Andrew Rasdal. The merger with ReShape cannot be completed without the approval of each of the proposals being voted on at the special meeting, including approval of the proposed reverse stock split.
Obalon Therapeutics, Inc Urges Stockholders to IMMEDIATELY Vote FOR All Proposals Related to the Merger with ReShape Lifesciences Inc
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.